Why disconnected oncology data is an enterprise problem

Most health systems do not lack data about their cancer programs. They lack a shared, governed way to connect it. That gap quietly shows up on the balance sheet, not just in the dashboard.

Fragmentation is expensive, not just inconvenient.

Referral data lives in one system, treatment and staging data in the EHR, trial enrollment in a separate CTMS, and outcomes tracking in a registry maintained by one analyst. Each system is fine on its own. Together, they cost teams the hours spent reconciling them before any decision can be made — and the opportunity cost of the decisions that get delayed or skipped entirely.

The real cost shows up three ways.

First, in capacity: sites don't know where the network has room until someone manually pulls a report. Second, in research: trial teams lose weeks assembling feasibility numbers that should take days. Third, in trust: when three teams present three different versions of the same metric, leadership stops trusting all of them.

Connective infrastructure beats another point solution.

The instinct is often to buy another analytics tool. The more durable fix is connective infrastructure — a governed layer that structures data once and serves it consistently to every team that needs it, without asking anyone to abandon the systems they already depend on.

That is the problem an intelligence layer is built to solve: not more data, but one trustworthy account of the data you already have.